Covalent Interactions of Nucleic Acids with Small Molecules and Their Repair 305
NHAc N
Ac
OH NOC 6 H 11 O 6
Ac
NHAc N
Ac
OSO 3 N
Ac
OAc
HO
NAc
NAc
NAc
N
N
N N
dR
NH 2
O
H
NH
Ac
N
N
HN
N
dR
HN
O
S
N
Me
NH 2
R
S
N
Me
NH
F NH 3 Cl
ONH 3 Cl
CYP450
10%
inactive glucuronate
CYP450
90%
inactive 3-, 5-, 7- and9-hydroxy metabolites
i ii
proximate carcinogen
iii
nitrenium intermediate
two identified products
from DNA binding
4
DF 203 (NSC 674495); R = H5F 203 (NSC 703786); R = F Phortress (NSC 71305)
b
a
Figure 8.14 (a) Metabolic activation of 2-acetylaminofluorene (AAF) and its binding to dG via a hypothetical
nitrenium intermediate. (b) Examples of benzothiazolyl anticancer agents. Processes: (i) sulfotransferase;
(ii) acetyl transferase; and (iii) binding to DNA in vitro or in vivo
NH 2
R NR" 2
N
NO 2
O
R
NHAc
N
N
NHR
Me 2 NNMe 2
NH
2-naphthylamine
R = R' = H; 4-aminobiphenyl
R = H, R' = O; 4-nitrobiphenyl
R=NH 2 , R' = H; benzidine
4-nitroquinolineN-oxide
2-acetylaminofluorene R = H; 4-aminoazobenzene
R = Me; 4-methylaminoazobenzene
auramine
Figure 8.13 Examples of N-aryl carcinogens